ZERO WINTERDEAL 2025: Bis zu 300 € Prämie + Gratis-Aktie + finanzen.net MSCI World-ETF -
Jetzt informieren!
SLI
2.047,46
PKT
+6,60
PKT
+0,32
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.11.21 | Holcim Buy | Deutsche Bank AG | |
| 18.11.21 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 18.11.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 18.11.21 | Givaudan Underperform | Bernstein Research | |
| 18.11.21 | Holcim Buy | UBS AG | |
| 18.11.21 | Zurich Insurance Buy | UBS AG | |
| 18.11.21 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 16.11.21 | ams-OSRAM Buy | Kepler Cheuvreux | |
| 16.11.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 16.11.21 | UBS Underweight | JP Morgan Chase & Co. | |
| 12.11.21 | Richemont Buy | UBS AG | |
| 12.11.21 | Richemont Overweight | Morgan Stanley | |
| 12.11.21 | Zurich Insurance Overweight | Morgan Stanley | |
| 12.11.21 | Richemont Outperform | RBC Capital Markets | |
| 12.11.21 | Holcim Outperform | Credit Suisse Group | |
| 12.11.21 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.11.21 | Zurich Insurance Overweight | Barclays Capital | |
| 11.11.21 | UBS Buy | Kepler Cheuvreux | |
| 11.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.21 | Givaudan Buy | UBS AG | |
| 10.11.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 10.11.21 | Novartis Buy | Jefferies & Company Inc. | |
| 09.11.21 | Roche Neutral | UBS AG | |
| 08.11.21 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.11.21 | ams-OSRAM Neutral | UBS AG | |
| 05.11.21 | UBS Buy | UBS AG | |
| 05.11.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.11.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.11.21 | Novartis Neutral | UBS AG | |
| 05.11.21 | UBS Sector Perform | RBC Capital Markets | |
| 05.11.21 | UBS Hold | Deutsche Bank AG | |
| 04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.21 | UBS Hold | Jefferies & Company Inc. | |
| 04.11.21 | UBS Neutral | JP Morgan Chase & Co. | |
| 04.11.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.11.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.11.21 | Roche Neutral | UBS AG | |
| 04.11.21 | Nestlé Hold | Jefferies & Company Inc. |